Author

Aya G. Halawi

Memorial Sloan Kettering Cancer CenterORCID 0000-0001-8275-4065Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Anthony F. DaniyaniD· 1 shared Christopher Austin KlebanoffiD· 1 shared Clara Lawry· 1 shared Gabryelle Kolk· 1 shared Katharine C. HsuiD· 1 shared Kyle B. LupoiD· 1 shared M. Kazim PanjwaniiD· 1 shared Rosa SottileiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anthony F. DaniyanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyJournal of Clinical InvestigationPeer-reviewedOct 20, 2026

Engineered NKG2C+ NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome

Kyle B. Lupo, M. Kazim Panjwani, Aya G. Halawi…·Katharine C. Hsu

This study shows that engineered NKG2C+ NK-like T cells have better antitumor effects and lower cytokine release syndrome risk than conventional CAR-T and CAR-NK cells.

5 citations

humanCITE-seq

𝕏 PostBluesky